US2018071260A1PendingUtilityA1
Methods of treating alpha adrenergic mediated conditions
Est. expiryJun 9, 2028(~1.9 yrs left)· nominal 20-yr term from priority
Inventors:Daniel W. GilJohn E. DonelloWenkui K. FangPhong X. NguyenKen ChowTodd M. HeidelbaughDario G. GomezMichael E. GarstSantosh C. Sinha
A61P 29/00A61K 31/4174C07D 233/48C07D 233/50A61K 31/4168A61P 25/00A61K 31/40A61K 9/0053
65
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Described herein are compounds for and methods of treating conditions or diseases in a subject by administering to the subject a pharmaceutical composition containing an effective amount of an α-adrenergic modulator. The compounds and methods are also useful for alleviating types of pain, acute, neuropathic and chronic.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method of treating gastritis in a mammal, the method comprising administering to the mammal in need of such treatment a pharmaceutically effective dose of N-(2,3-dichlorobenzyl)-4,5-dihydro-1H-imidazol-2-amine having the following structure:
or a pharmaceutically acceptable salt thereof.
2 . The method of claim 1 , wherein the dose is administered by an oral route.
3 . The method of claim 2 , wherein the dose is orally administered in the form of a tablet, liquid, capsule or powder.
4 . The method of claim 1 , wherein the dose is administered by a transdermal, parenteral, subcutaneous, intranasal, intrathecal, intramuscular, intravenous or intrarectal route.
5 . The method of claim 1 , wherein the mammal is a human.Join the waitlist — get patent alerts
Track US2018071260A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.